| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.600 | None | 0.886 | 77 | 5 | 1992 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.100 | None | 0.921 | 38 | 0 | 1997 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.100 | None | 1.000 | 30 | 0 | 1989 | 2020 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
group | 0.100 | None | 0.800 | 25 | 0 | 1997 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 0.895 | 19 | 2 | 1999 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.889 | 18 | 4 | 2005 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 2001 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.100 | None | 0.750 | 16 | 3 | 1997 | 2016 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 15 | 4 | 2003 | 2017 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2001 | 2018 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 1997 | 2014 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 12 | 0 | 2012 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.100 | None | 1.000 | 11 | 2 | 2013 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.100 | None | 0.700 | 10 | 0 | 2007 | 2017 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.100 | None | 0.800 | 10 | 3 | 2006 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2012 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2000 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2012 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2012 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.090 | None | 0.889 | 9 | 4 | 2002 | 2017 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.090 | None | 1.000 | 9 | 3 | 2008 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2007 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2003 | 2018 | |||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.090 | None | 0.889 | 9 | 1 | 1999 | 2017 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2003 | 2019 |